These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32269183)

  • 21. Serum calcitonin nadirs to undetectable levels within 1 month of curative surgery in medullary thyroid cancer.
    Andrade F; Rondeau G; Boucai L; Zeuren R; Shaha AR; Ganly I; Vaisman F; Corbo R; Tuttle M
    Arch Endocrinol Metab; 2019; 63(2):137-141. PubMed ID: 30916162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Basal and stimulated calcitonin for the diagnosis of medullary thyroid cancer: updated thresholds and safety assessment.
    Fugazzola L; Di Stefano M; Censi S; Repaci A; Colombo C; Grimaldi F; Magri F; Pagotto U; Iacobone M; Persani L; Mian C
    J Endocrinol Invest; 2021 Mar; 44(3):587-597. PubMed ID: 32656666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Procalcitonin: a marker for the diagnosis and follow-up of patients with medullary thyroid carcinoma.
    Algeciras-Schimnich A; Preissner CM; Theobald JP; Finseth MS; Grebe SK
    J Clin Endocrinol Metab; 2009 Mar; 94(3):861-8. PubMed ID: 19088163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurement of Basal Serum Calcitonin for the Diagnosis of Medullary Thyroid Cancer.
    Allelein S; Ehlers M; Morneau C; Schwartz K; Goretzki PE; Seppel T; Feldkamp J; Krieg A; Knoefel WT; Kuebart A; Haase M; Dringenberg T; Schmid C; Schott M
    Horm Metab Res; 2018 Jan; 50(1):23-28. PubMed ID: 29169190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcitonin and procalcitonin in patients with medullary thyroid cancer or bacterial infection.
    Kaczka K; Mikosiński S; Fendler W; Celnik A; Pomorski L
    Adv Clin Exp Med; 2012; 21(2):169-78. PubMed ID: 23214280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Procalcitonin for detecting medullary thyroid carcinoma: a systematic review.
    Trimboli P; Seregni E; Treglia G; Alevizaki M; Giovanella L
    Endocr Relat Cancer; 2015 Jun; 22(3):R157-64. PubMed ID: 25934688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. THE COMBINED USE OF CALCITONIN DOUBLING TIME AND
    Yang JH; Camacho CP; Lindsey SC; Valente FOF; Andreoni DM; Yamaga LY; Wagner J; Biscolla RPM; Maciel RMB
    Endocr Pract; 2017 Aug; 23(8):942-948. PubMed ID: 28614009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discordance in thyroglobulin measurements by radioimmunoassay and immunometric assay: a useful means of identifying thyroglobulin assay interference.
    Crane MS; Strachan MW; Toft AD; Beckett GJ
    Ann Clin Biochem; 2013 Sep; 50(Pt 5):421-32. PubMed ID: 23847033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcitonin measurement in fine-needle aspirate washout fluid by electrochemiluminescence immunoassay for thyroid tumors.
    Kihara M; Hirokawa M; Kudo T; Hayashi T; Yamamoto M; Masuoka H; Higashiyama T; Fukushima M; Ito Y; Miya A; Miyauchi A
    Thyroid Res; 2018; 11():15. PubMed ID: 30450128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen.
    Woliński K; Kaznowski J; Klimowicz A; Maciejewski A; Łapińska-Cwojdzińska D; Gurgul E; Car AD; Fichna M; Gut P; Gryczyńska M; Ruchała M
    Endokrynol Pol; 2017; 68(4):434-437. PubMed ID: 28585679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrocalcitonin Is a Novel Pitfall in the Routine of Serum Calcitonin Immunoassay.
    Alves TG; Kasamatsu TS; Yang JH; Meneghetti MC; Mendes A; Kunii IS; Lindsey SC; Camacho CP; Dias da Silva MR; Maciel RM; Vieira JG; Martins JR
    J Clin Endocrinol Metab; 2016 Feb; 101(2):653-8. PubMed ID: 26647152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baseline and stimulated calcitonin: Thresholds for the diagnosis of medullary thyroid cancer.
    Fugazzola L
    Ann Endocrinol (Paris); 2019 Jun; 80(3):191-192. PubMed ID: 31053250
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical outcomes of patients with hypercalcitoninemia after initial treatment for medullary thyroid cancer and postoperative serum calcitonin cutoffs for predicting structural recurrence.
    Cho YY; Jang HW; Jang JY; Kim TH; Choe JH; Kim JH; Kim JS; Kim SW; Chung JH
    Head Neck; 2016 Oct; 38(10):1501-8. PubMed ID: 27062421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical laboratory verification of thyroglobulin concentrations in the presence of autoantibodies to thyroglobulin: comparison of EIA, radioimmunoassay and LC MS/MS measurements in an Urban Hospital.
    Wheeler SE; Liu L; Blair HC; Sivak R; Longo N; Tischler J; Mulvey K; Palmer OMP
    BMC Res Notes; 2017 Dec; 10(1):725. PubMed ID: 29221487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
    Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
    World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of spurious hypercalcitoninemia: a cautionary tale on the use of plasma calcitonin assays in the screening of patients with thyroid nodules for neoplasia.
    Uwaifo GI; Remaley AT; Stene M; Reynolds JC; Yen PM; Snider RH; Becker KL; Sarlis NJ
    J Endocrinol Invest; 2001 May; 24(5):361-9. PubMed ID: 11407657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ghrelin in human medullary thyroid carcinomas.
    Morpurgo PS; Cappiello V; Verga U; Vicentini L; Vaghi I; Lauri E; Nebuloni M; Beck-Peccoz P; Spada A
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):437-41. PubMed ID: 16181236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of serum calcitonin and procalcitonin in detecting medullary thyroid carcinoma among patients with thyroid nodules.
    Giovanella L; Verburg FA; Imperiali M; Valabrega S; Trimboli P; Ceriani L
    Clin Chem Lab Med; 2013 Jul; 51(7):1477-81. PubMed ID: 23314540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Procalcitonin measurement to screen medullary thyroid carcinoma: A prospective evaluation in a series of 2705 patients with thyroid nodules.
    Giovanella L; Imperiali M; Piccardo A; Taborelli M; Verburg FA; Daurizio F; Trimboli P
    Eur J Clin Invest; 2018 Jun; 48(6):e12934. PubMed ID: 29635700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of sensitive PDN-21 (katacalcin) determination as tumor marker in medullary thyroid carcinoma.
    Blind E; Raue F; Klaiber T; Zink A; Schroth J; Buhr H; Ziegler R
    J Endocrinol Invest; 1992 Feb; 15(2):93-8. PubMed ID: 1569295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.